Course Exam
301907 VO Development of novel cancer immunotherapies (2022W)
from target identification through target validation to clinical trials
Labels
ON-SITE
WHEN?
Monday
27.02.2023
10:00 - 12:00
BZB/Seminarraum 1/2, 6.Ebene 6.501/6.504, Dr.-Bohr-Gasse 9, 1030 Wien
Registration/Deregistration
Note: The time of your registration within the registration period has no effect on the allocation of places (no first come, first served).
- Registration is open from Sa 01.10.2022 09:00 to Su 26.02.2023 09:00
- Deregistration possible until Su 26.02.2023 09:00
Examiners
Information
Assessment and permitted materials
written exam
Minimum requirements and assessment criteria
100-87%: Sehr Gut ( I ); 87,99-75%: Gut (2); 74,99-62%: Befriedigend (3); 6 I ,99-50%: Genügend (4); < 50%: Nicht Genügend (5)
Last modified: We 12.07.2023 13:47